Injection technique and site rotation warrant attention
Cost Comparison Table Insurance Coverage Saxenda: FDA-approved for weight loss Some plans cover with prior authorization May have quantity limits or step therapy requirements Ozempic: FDA-approved for diabetes, not weight loss Often covered for diabetic patients Rarely covered for weight loss alone Wegovy: FDA-approved for weight loss Coverage varies widely Many plans exclude weight loss medications Cost Efficiency When comparing cost per outcome: Saxenda: At $200/month for 12 months ($2,400) producing 15-18 pounds loss = ~$133-160 per pound lost Semaglutide: At $199/month for 12 months ($2,388) producing 30-35 pounds loss = ~$68-80 per pound lost Semaglutide provides substantially better value when considering weight loss achieved per dollar spent
Persistent diarrhea that continues for a long time should not be ignored because it may increase the risk of dehydration or nutritional problems
If youre going to do it, it needs to be part of an overall plan with your doctors input and supervision, and not to simply chase a number, he says
Quickstart Highlights Retatrutide is a first-in-class triple agonist it engages the GLP-1, GIP, and glucagon receptors at the same time [1] and has been studied for substantial weight loss and broad metabolic improvement in obesity and type 2 diabetes [2] [3]
A 10mg vial with 2.0mL of bacteriostatic water gives you 5mg/mL
